Bd launches fully automated high-throughput molecular diagnostic platform for u.s. laboratories

Franklin lakes, n.j., aug. 25, 2021 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced that it has launched a new, fully automated high-throughput diagnostic system using robotics and sample management software algorithms to set a new standard in automation for infectious disease molecular testing in core laboratories and other centralized laboratories in the united states.
BDX Ratings Summary
BDX Quant Ranking